Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder
Journal of Psychiatry & Neuroscience , 07/01/09
Andreazza AC et al. - This study indicates a possible tyrosine nitration-induced damage in patients with bipolar disorder that is present from the early stage of illness. This study also indicates that patients in the late stage of illness demonstrate enhanced activity of GR and GST, which could suggest the involvement of a compensatory system in bipolar disorder.
Methods- Matched 30 patients in the early stage and 30 patients in the late stage of bipolar disorder, diagnosed according to DSM-IV criteria, with 60 healthy controls (30 matched for each group of patients).
- Measured symptomatic status using the Hamilton Rating Scale for Depression and the Young Mania Rating Scale.
- We found a significant increase in 3-nitrotyrosine levels among patients in the early (p < 0.010) and late (p < 0.010) stages of bipolar disorder.
- The activity of GR and GST was increased only among patients in the late stage of illness.
- Glutathione peroxidase activity and carbonyl content did not differ among the groups.
Today in Psychiatry...keeping you current
Receive free subspecialty "5-minute updates" via email
An algorithm for the pharmacological treatment of depression
Acta Psychiatrica Scandinavica, 11/04/09
Is Monotherapy as Good as Polypharmacy in Long-Term Treatment of Bipolar Disorder
Canadian Journal of Psychiatry, 11/16/09
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/28/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


